Skip to content
Disclosery

EXANE DERIVATIVES: PEP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PEP, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,723 PEP shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,723 shares
    Change vs previous 13F -81 shares

    0.36% of the 13F portfolio, value $620,349.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,804 shares
    Change vs previous 13F -365 shares

    0.18% of the 13F portfolio, value $636,674.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 4,169 shares
    Change vs previous 13F -2,821 shares

    0.18% of the 13F portfolio, value $724,171.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 6,990 shares
    Change vs previous 13F +18 shares

    0.26% of the 13F portfolio, value $1,051,328.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 6,972 shares
    Change vs previous 13F +331 shares

    0.25% of the 13F portfolio, value $1,066,413.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 6,641 shares
    Change vs previous 13F -10,164 shares

    0.28% of the 13F portfolio, value $939,328.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 16,805 shares
    Change vs previous 13F -16,978 shares

    0.76% of the 13F portfolio, value $2,492,066.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 33,783 shares
    Change vs previous 13F not available

    1.53% of the 13F portfolio, value $4,682,065.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).